Contera Pharma: Partnerships and Licensing

Partnership and licensing opportunities from Contera Pharma.

 

Partnership Title: Oligonucleotide discovery platform

By combining our expertise in genetics and disease biology with our unique platforms that allow us to evaluate multiple modalities and chemistries at-scale we can uncover the ideal RNA-based corrective therapeutic to target the genetic roots of disease.

• Licencing Out
  We offer our products to other companies on an 'out-licensing' basis.

• Research and Development
  We offer co-development opportunities.

• Active Pharmaceutical Ingredients
  - Discovery Platforms-Small Molecules

• Biopharmaceuticals
  - Biopharmaceuticals-Development Platforms
  - Biopharmaceuticals-Discovery Platforms
  - Biopharmaceuticals-Technology

 

Partnership Title: SpliceMatrix – small molecule discovery platform

By combining our expertise in genetics and disease biology with our unique platforms that allow us to evaluate multiple modalities and chemistries at-scale we can uncover the ideal RNA-based corrective therapeutic to target the genetic roots of disease.

• Licencing Out
  We offer our products to other companies on an 'out-licensing' basis.

• Research and Development
  We offer co-development opportunities.

• Active Pharmaceutical Ingredients
  - Discovery Platforms-Small Molecules

• Biopharmaceuticals
  - Biopharmaceuticals-Discovery Platforms

Claim This Profile

This is the Partnership and Licensing section of the company profile page for Contera Pharma on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.